ProFound AI

Discover the ProFound impact of world-class artificial intelligence for digital breast tomosynthesis

It’s time to revolutionize the way you read.

ProFound AI

A reading revolution in tomosynthesis has arrived.

The difference is ProFound.

ProFound AI is the first and only FDA-cleared 3D tomosynthesis software using AI. The high-performing, concurrent-read, cancer detection and workflow solution rapidly analyzes each tomosynthesis image accurately, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy.

Built on the latest deep-learning and artificial intelligence technology, ProFound AI for digital breast tomosynthesis is clinically proven to assist radiologists in addressing the challenges of reading tomosynthesis cases by:

  • Improving cancer detection rates
  • Reducing false positives and unnecessary patient recalls
  • Decreasing reading times

Compatible with leading digital breast tomosynthesis systems

Schedule a Demo

FDA Cleared, CE Marked, Health Canada Licensed

Brochure

White Paper

Podcast

Clinical Performance Benefits

  • 8.0% average increase in sensitivity
  • 6.9% average increase in specificity
  • 7.2% average reduction in recalls
  • 5.7% average improvement in radiologist AUC

Workflow Benefits

  • 52.7% reduction in reading time
  • Certainty of Finding scores assist in prioritizing caseload and clinical decision-making

 Dr. Mark Traill, radiologist at Metro Health, describes how ProFound AI can help detect breast cancer earlier. Courtesy of Fox 17 News at 10:00pm from Grand Rapids, Michigan.

Segment on ProFound AI, featuring Jay Smith, Director of Imaging at McKenzie Health System, and breast cancer survivor Margaret Rhead. Courtesy of Fox 66 from Flint, Michigan

In this video from RSNA 2019, Rodney Hawkins, vice president of product management for iCAD, discusses the advantages of using ProFound AI for Digital Breast Tomosynthesis, the first and only FDA-cleared software for DBT with AI.

Regional Medical Imaging Adopts iCAD’s Innovative ProFound AI™ Solution for Digital Breast Tomosynthesis. - Read More

Randy Hicks, M.D., MBA, radiologist, co-owner and CEO at Regional Medical Imaging shares his excitement and discusses the value ProFound AI provides to his facility and patients.

Certainty of Finding and Case Scores

The ProFound AI algorithm is trained to detect malignant soft tissue densities and calcifications. Certainty of Finding and Case Scores are assigned to each detection and each case respectively. Certainty of Finding and Case Scores are relative scores computed by the ProFound AI algorithm and represent the algorithm’s confidence that a detection or case is malignant. The scores are represented on a 0% to 100% scale. A higher score indicates a higher level of confidence in the malignancy of the detection or case. The scores are calibrated to a population of 50% prevalence of cancer and should be interpreted as the probability of the detection or case correctly being identified as malignant in a population of 50% cancers and 50% non-cancers. The Certainty of Finding and Case Scores serve as a guide to the interpreting radiologist to aid in determining if a suspicious finding or case needs further workup.

Certainty of Finding Score

Certainty of Finding Scores are assigned to each detection identified by the ProFound AI algorithm. The Certainty of Finding Score represents how confident the algorithm is that the detection is malignant.

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.

Case Score

Case Scores are assigned to each case by the ProFound AI algorithm. The Case Score represents how confident the algorithm is that a case is malignant. All cases, including those without detections, will be assigned a Case Score.

Each tomosynthesis exam analyzed by PowerLook Tomo Detection 2.0 is assigned a Case Score from 0 – 100%.

Platform

ProFound AI for digital breast tomosynthesis runs on the industry-leading PowerLook server platform with NVIDIA Graphical Processing Units (GPU). PowerLook is a flexible and reliable DICOM platform that easily integrates with image modalities, mammography review workstations, PACS, and image storage systems. Leveraging the latest in GPU technology, the algorithm can rapidly process a 4-view tomosynthesis case, ensuring results are available to radiologists in the most efficient manner.

Resources

© 2019, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.

Each tomosynthesis exam analyzed by PowerLook Tomo Detection 2.0 is assigned a Case Score from 0 – 100%.

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.

ProFound AI

Discover the ProFound impact of world-class artificial intelligence for digital breast tomosynthesis

It’s time to revolutionize the way you read

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.

Each tomosynthesis exam analyzed by PowerLook Tomo Detection 2.0 is assigned a Case Score from 0 – 100%.

PowerLook Tomo Detection 2.0 introduces Certainty of Finding scores to assist radiologists in their clinical decision making.